• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用不良事件分层结构进行临床试验信号检测的统计学方法:方法学文献的范围综述。

Statistical methods leveraging the hierarchical structure of adverse events for signal detection in clinical trials: a scoping review of the methodological literature.

机构信息

Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

William Harvey Research Institute, Queen Mary University of London, London, UK.

出版信息

BMC Med Res Methodol. 2024 Oct 28;24(1):253. doi: 10.1186/s12874-024-02369-1.

DOI:10.1186/s12874-024-02369-1
PMID:39468481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11514772/
Abstract

BACKGROUND

In randomised controlled trials with efficacy-related primary outcomes, adverse events are collected to monitor potential intervention harms. The analysis of adverse event data is challenging, due to the complex nature of the data and the large number of unprespecified outcomes. This is compounded by a lack of guidance on best analysis approaches, resulting in widespread inadequate practices and the use of overly simplistic methods; leading to sub-optimal exploitation of these rich datasets. To address the complexities of adverse events analysis, statistical methods are proposed that leverage existing structures within the data, for instance by considering groupings of adverse events based on biological or clinical relationships.

METHODS

We conducted a methodological scoping review of the literature to identify all existing methods using structures within the data to detect signals for adverse reactions in a trial. Embase, MEDLINE, Scopus and Web of Science databases were systematically searched. We reviewed the analysis approaches of each method, extracted methodological characteristics and constructed a narrative summary of the findings.

RESULTS

We identified 18 different methods from 14 sources. These were categorised as either Bayesian approaches (n=11), which flagged events based on posterior estimates of treatment effects, or error controlling procedures (n=7), which flagged events based on adjusted p-values while controlling for some type of error rate. We identified 5 defining methodological characteristics: the type of outcomes considered (e.g. binary outcomes), the nature of the data (e.g. summary data), the timing of the analysis (e.g. final analysis), the restrictions on the events considered (e.g. rare events) and the grouping systems used.

CONCLUSIONS

We found a large number of analysis methods that use the group structures of adverse events. Continuous methodological developments in this area highlight the growing awareness that better practices are needed. The use of more adequate analysis methods could help trialists obtain a better picture of the safety-risk profile of an intervention. The results of this review can be used by statisticians to better understand the current methodological landscape and identify suitable methods for data analysis - although further research is needed to determine which methods are best suited and create adequate recommendations.

摘要

背景

在与疗效相关的主要结局的随机对照试验中,收集不良事件以监测潜在的干预危害。由于数据的复杂性和未指定的结果数量众多,不良事件数据的分析具有挑战性。由于缺乏最佳分析方法的指导,这一问题更加复杂,导致广泛存在分析方法不充分的情况,以及过度简单化方法的使用;导致这些丰富数据集没有得到最佳利用。为了解决不良事件分析的复杂性,提出了利用数据中现有结构的统计方法,例如根据不良事件的生物学或临床关系进行分组。

方法

我们对文献进行了方法学范围的综述,以确定所有使用数据中结构来检测试验中不良反应信号的现有方法。我们系统地检索了 Embase、MEDLINE、Scopus 和 Web of Science 数据库。我们审查了每种方法的分析方法,提取了方法学特征,并对研究结果进行了叙述性总结。

结果

我们从 14 个来源中确定了 18 种不同的方法。这些方法分为贝叶斯方法(n=11)和错误控制程序(n=7),前者根据治疗效果的后验估计标记事件,后者根据调整后的 p 值并控制某种类型的错误率来标记事件。我们确定了 5 个定义性方法特征:所考虑的结局类型(例如二分类结局)、数据性质(例如汇总数据)、分析时间(例如最终分析)、所考虑事件的限制(例如罕见事件)和使用的分组系统。

结论

我们发现了大量使用不良事件组结构的分析方法。该领域的连续方法进展突出表明,需要更好的实践。使用更适当的分析方法可以帮助试验人员更好地了解干预措施的安全性风险概况。本综述的结果可被统计学家用于更好地了解当前的方法学现状,并确定适合数据分析的方法——尽管需要进一步研究来确定哪些方法最适合并制定适当的建议。

相似文献

1
Statistical methods leveraging the hierarchical structure of adverse events for signal detection in clinical trials: a scoping review of the methodological literature.利用不良事件分层结构进行临床试验信号检测的统计学方法:方法学文献的范围综述。
BMC Med Res Methodol. 2024 Oct 28;24(1):253. doi: 10.1186/s12874-024-02369-1.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.一种用于随机临床试验中安全信号检测的贝叶斯荟萃分析方法。
Clin Trials. 2017 Apr;14(2):192-200. doi: 10.1177/1740774516683920. Epub 2017 Jan 6.
4
Statistical methods for the analysis of adverse event data in randomised controlled trials: a scoping review and taxonomy.随机对照试验中不良事件数据分析的统计方法:范围综述和分类法。
BMC Med Res Methodol. 2020 Nov 30;20(1):288. doi: 10.1186/s12874-020-01167-9.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
7
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
8
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充:一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.
9
Improving adverse drug event reporting by healthcare professionals.提高医疗保健专业人员对药物不良事件的报告率。
Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD012594. doi: 10.1002/14651858.CD012594.pub2.
10
Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.苦参根治疗慢性乙型肝炎与不干预或安慰剂对照
Cochrane Database Syst Rev. 2019 Apr 3;4(4):CD013089. doi: 10.1002/14651858.CD013089.pub2.

本文引用的文献

1
Assessing the incidence and severity of drug adverse events: a Bayesian hierarchical cumulative logit model.评估药物不良反应事件的发生率和严重程度:贝叶斯层次累积对数模型。
J Biopharm Stat. 2024 Mar;34(2):276-295. doi: 10.1080/10543406.2023.2194385. Epub 2023 Apr 4.
2
Application of Bayesian approaches in drug development: starting a virtuous cycle.贝叶斯方法在药物研发中的应用:开启良性循环。
Nat Rev Drug Discov. 2023 Mar;22(3):235-250. doi: 10.1038/s41573-023-00638-0. Epub 2023 Feb 15.
3
Adverse Event Reporting Quality in Cancer Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy: A Systematic Review.
免疫检查点抑制剂治疗的癌症临床试验中不良事件报告质量的系统评价。
Front Immunol. 2022 Jul 7;13:874829. doi: 10.3389/fimmu.2022.874829. eCollection 2022.
4
BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA-Coded Adverse Events in Randomized Controlled Trials.BAHAMA:一种用于检测随机对照试验中 MedDRA 编码不良事件的贝叶斯层次模型。
Drug Saf. 2022 Sep;45(9):961-970. doi: 10.1007/s40264-022-01208-w. Epub 2022 Jul 15.
5
Improving the analysis of adverse event data in randomized controlled trials.改进随机对照试验中不良事件数据的分析。
J Clin Epidemiol. 2022 Apr;144:185-192. doi: 10.1016/j.jclinepi.2021.12.023. Epub 2021 Dec 23.
6
Assessing safety at the end of clinical trials using system organ classes: A case and comparative study.使用系统器官分类评估临床试验结束时的安全性:案例和比较研究。
Pharm Stat. 2021 Nov;20(6):1278-1287. doi: 10.1002/pst.2148. Epub 2021 Jun 24.
7
PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews.PRISMA-S:用于在系统评价中报告文献检索的 PRISMA 声明的扩展。
Syst Rev. 2021 Jan 26;10(1):39. doi: 10.1186/s13643-020-01542-z.
8
Statistical methods for the analysis of adverse event data in randomised controlled trials: a scoping review and taxonomy.随机对照试验中不良事件数据分析的统计方法:范围综述和分类法。
BMC Med Res Methodol. 2020 Nov 30;20(1):288. doi: 10.1186/s12874-020-01167-9.
9
Toward a framework for the design, implementation, and reporting of methodology scoping reviews.迈向设计、实施和报告方法范围综述的框架。
J Clin Epidemiol. 2020 Nov;127:191-197. doi: 10.1016/j.jclinepi.2020.07.014. Epub 2020 Jul 26.
10
Understanding current practice, identifying barriers and exploring priorities for adverse event analysis in randomised controlled trials: an online, cross-sectional survey of statisticians from academia and industry.了解当前实践情况,识别随机对照试验中不良事件分析的障碍,并探讨其优先事项:对学术界和业界统计学家进行的在线横断面调查。
BMJ Open. 2020 Jun 11;10(6):e036875. doi: 10.1136/bmjopen-2020-036875.